🔎 Trials Near Me

Beranda › Tumor Otak › Missouri

Uji klinis Tumor Otak di Missouri

13 studi untuk Tumor Otak mencari peserta di lokasi di Missouri.

Kota di Missouri

Teks studi resmi (Bahasa Inggris)

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Washington University School of Medicine Siteman Cancer Center, St Louis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Washington University, St Louis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05786924

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • dan 19 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04511013

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • Saint Luke's Cancer Institute, Kansas City
  • Washington University School of Medicine, St Louis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06253871

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

  • Washington University School of Medicine, St Louis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07428616

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

  • Siteman Cancer Center at Washington University, St Louis
Menerima pesertaFase 1
36 Months – 22 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT03911388

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

  • Washington University School of Medicine/Saint Louis Children's Hospital, St Louis
Menerima pesertaStudi observasional
Usia 8 hingga 21 · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT06185686

REMASTer: REcurrent Brain Metastases After SRS Trial

  • WashU, St Louis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT05124912

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • dan 3 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT03550391

Window of Opportunity Study of DSP-0390 in Gliomas

  • Washington University School of Medicine, St Louis
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT06636162

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

  • Washington University School of Medicine, St Louis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT07462507

7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)

  • University of Missouri, Columbia
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Des 2025 · NCT07175077

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
  • Saint Francis Medical Center, Cape Girardeau
  • Capital Region Southwest Campus, Jefferson City
  • dan 10 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Okt 2025 · NCT03418961

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.